RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
13.75
+0.69 (5.28%)
At close: May 12, 2025, 4:00 PM
14.00
+0.25 (1.82%)
After-hours: May 12, 2025, 5:53 PM EDT
RxSight Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for RxSight stock have an average target of 38.5, with a low estimate of 16 and a high estimate of 73. The average target predicts an increase of 180.00% from the current stock price of 13.75.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for RxSight stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 5 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Initiates $18 | Hold | Initiates | $18 | +30.91% | Apr 15, 2025 |
| UBS | UBS | Strong Buy → Hold Downgrades $45 → $16 | Strong Buy → Hold | Downgrades | $45 → $16 | +16.36% | Apr 9, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $22 → $17 | Hold | Maintains | $22 → $17 | +23.64% | Apr 7, 2025 |
| JP Morgan | JP Morgan | Buy → Sell Downgrades $40 → $17 | Buy → Sell | Downgrades | $40 → $17 | +23.64% | Apr 4, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $35 → $22 | Hold | Maintains | $35 → $22 | +60.00% | Apr 3, 2025 |
Financial Forecast
Revenue This Year
173.71M
from 139.93M
Increased by 24.14%
Revenue Next Year
211.00M
from 173.71M
Increased by 21.47%
EPS This Year
-0.67
from -0.71
EPS Next Year
-0.49
from -0.67
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 201.5M | 257.9M | 321.7M | |
| Avg | 173.7M | 211.0M | 254.7M | |
| Low | 158.2M | 181.0M | 208.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 44.0% | 48.5% | 52.5% | |
| Avg | 24.1% | 21.5% | 20.7% | |
| Low | 13.1% | 4.2% | -1.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.56 | -0.17 | 0.18 |
| Avg | -0.67 | -0.49 | -0.23 |
| Low | -0.79 | -0.91 | -0.87 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.